Siirry sisältöön
Global sound
The Bio Report

The Bio Report

Addressing Treatment Gaps in Gout

· 37 min · Jakso 173

Jakson kuvaus

Gout may be one of the oldest known forms of arthritis, but it remains widely misunderstood, undertreated, and a source of silent suffering for millions of people who are often blamed for their disease rather than offered effective care. Current therapies to lower urate levels suffer from limitations and safety challenges. Crystalys Therapeutics is in late-stage development of a next‑generation urate inhibitor that is already approved in Japan and China. Crystalys CEO James Mackay discusses the biology of gout, why standard therapies often fail to get uric acid to target levels, and how the company’s next‑generation URAT1 inhibitor may fill the treatment gap and change daily life for patients living with moderate to severe gout.

Sivusto: thebioreport.podbean.com

Livenä, viimeisin tunti: 8 445 kappaletta 3 566 asemalla 128 maassa

Löydä maailma radion kautta

Lisää tapoja löytää (7)

Kuulitko jotain hyvää? Tallenna se tai avaa se suoraan Spotifyssa.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Nostalgie Aix-en-ProvenceJatka kuuntelua